Methods, systems and circuits evaluate a subject's risk of developing type 2 diabetes or having prediabetes using at least one defined mathematical model of risk of progression that can stratify risk for patients having the same glucose measurement. The model may include NMR derived measurements of GlycA and a plurality of selected lipoprotein components of at least one biosample of the subject.
申请公布号
AU2013271432(A1)
申请公布日期
2014.12.18
申请号
AU20130271432
申请日期
2013.06.07
申请人
LIPOSCIENCE, INC.
发明人
OTVOS, JAMES D.;SHALAUROVA, IRINA Y.;BENNETT, DENNIS W.;WOLAK-DINSMORE, JUSTYNA E.;O'CONNELL, THOMAS M.;MERCIER, KELLY